1)  fluoroquinolone
氟喹诺酮类抗菌素
2)  fluoroquinolones
氟喹诺酮
1.
Simultaneous Determination of Sulfonamides and Fluoroquinolones Residues in Pork by Solid-phase Extraction and High Performance Liquid Chromatography;
固相萃取-高效液相色谱法同时测定猪肉中磺胺类和氟喹诺酮类兽药残留量
2.
Interactions Between Fluoroquinolones and Bovine Serum Albumin by Fluorescence Method and Affinity Capillary Electrophoresis;
亲和毛细管电泳法和荧光法研究氟喹诺酮类药物与牛血清白蛋白的相互作用
3.
Mutant prevention concentration of fluoroquinolones for Baumannii acinetobacter and its ciprofloxacin induced mutant strains;
氟喹诺酮类药物对鲍曼不动杆菌及其环丙沙星诱导突变株的防耐药突变浓度
3)  fluroquinolone
氟喹诺酮
1.
The action mechanism of DNA Gyrase with the tittled compounds,selection and the structure- activity relationships of fluroquinolones are reviewed.
氟喹诺酮类药物具有广谱抗菌活性 ,本文就其与 DNA促旋酶作用机制、选择性及药物的构效关系作一简要综
2.
Objective Shigellosis was investigated among outpatients with diarrhea in Wuhan, serotype distribution and drug resistance of Shigellae was analyzed, the mechanism of fluroquinolones-resistant was studied and a genotyping method for Shigella spp.
目的和意义 通过调查武汉市2004年流行季节门诊腹泻患者志贺菌感染状况,分析志贺菌血清型分布及耐药现状,并与2003年做相关比较,研究志贺菌中氟喹诺酮作用靶位点的改变导致氟喹诺酮耐药的机制,并用分子生物学方法对志贺菌进行基因分型,为志贺菌耐药性监测、临床合理用药、新药和疫苗开发及流行病学研究提供理论依据。
4)  Fluoroquinolone
氟喹诺酮
1.
Relation between fluoroquinolones-resistant and mutation of grlA and grlB gene in Staphylococcus aureus;
金黄色葡萄球菌氟喹诺酮的耐药性与grlA、grlB突变的关系
2.
Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)-phenyl]-ethyl]-piperazin-1-yl}-fluoroquinolones;
7-{4-[2-[2-取代-4-((5S)-5-乙酰胺甲基-2-氧代-噁唑烷-3-基)苯基]乙基]哌嗪-1-基}-氟喹诺酮类化合物的合成与抗菌活性
3.
A Study on the Difference of Efflux Protein Expression between Klebsiella Pneumoniae Used in Vitro Fluoroquinolone and Ones Not Used;
氟喹诺酮体外诱导肺炎克雷伯菌外排蛋白表达差异的研究
5)  Afloquanone
氟喹酮
1.
METHODS Afloquanone was prepared,taking 2-aminio-(5-nitrobenzoic) acid as initial material,followed by condensation,reduction,protection,annulation,halogen exchange,and deprotection,totally in 7 steps.
目的合成氟喹酮并改进工艺。
6)  fluoroquinolone
氟喹啉酮
参考词条
补充资料：喹诺酮类抗菌药
分子式：
CAS号：

性质：属全合成抗菌药，包括一代、二代、三代喹诺酮类。是DNA螺旋酶抑制剂。最早上市的品种为1962年合成的萘啶酸，中国临床早期使用的品种为二代吡哌酸，两药主要作用于阴性杆菌尿路感染。三代喹诺酮类包括环丙沙星、氧氟沙星、诺氟沙星。其抗菌谱广，包括阳性菌、阴性菌及绿脓杆菌，抗菌活性明显增强。喹诺酮类抗菌药主要用于尿路感染、肠道感染及皮肤软组织感染，不良反应少。其主要不良反应为胃肠道反应、中枢神经系统反应、皮肤反应、软骨组织的不良反应及光敏反应。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。